From: Childhood cancer in Gondar University Hospital, Northwest Ethiopia
Type of malignancy | Sex | Age | Total | ||||
---|---|---|---|---|---|---|---|
Female | Male | <1 year | 1–5 year | 5–10 year | ≥10 year | ||
Hematological malignancy | 12 (27.9 %) | 31 (72.1 %) | 3 (7.0 %) | 8 (18.6 %) | 11 (25.6 %) | 21 (48.8 %) | 43 (60.6 %) |
Wilms tumor | 5 (38.5 %) | 8 (61.5 %) | 0 | 9 (69.2 %) | 4 (30.8 %) | 0 | 13 (18.3 %) |
Neuroblastoma | 2 (40.0 %) | 3 (60.0 %) | 0 | 2 (40.0 %) | 2 (40.0 %) | 1 (20.0 %) | 5 (7.0 %) |
Rhabdomyosarcoma | 0 | 3 (100.0 %) | 0 | 0 | 1 (33.3 %) | 2 (66.7 %) | 3 (4.2 %) |
Brain tumor | 1 (33.3 %) | 2 (66.7 %) | 0 | 0 | 1 (33.3 %) | 2 (66.7 %) | 3 (4.2 %) |
Hepatoblastoma | 0 | 2 (100.0 %) | 0 | 2 (100.0 %) | 0 | 0 | 2 (2.8 %) |
Retinoblastoma | 0 | 1 (100.0 %) | 0 | 0 | 1 (100.0 %) | 0 | 1 (1.4 %) |
Osteosarcoma | 1 (100.0 %) | 0 | 0 | 0 | 1 (100.0 %) | 0 | 1 (1.4 %) |
Total | 21 (29.6 %) | 50 (70.4 %) | 3 (4.2 %) | 19 (26.8 %) | 23 (32.4 %) | 26 (36.6 %) | 71 (100 %) |